Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease
Authors
Keywords
AZA, Azacytidine, Decitabine, DAC, Treg, Regulatory T cells, GVHD, Graft-versus-host disease, Chronic graft-versus-host disease, Sclerodermic graft-versus-host disease
Journal
Journal of Hematology & Oncology
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-04
DOI
10.1186/s13045-016-0281-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Azacytidine Enhances Regulatory T-Cells In Vivo and Prevents Experimental Xenogeneic Graft-Versus-Host Disease
- (2016) Grégory Ehx et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis
- (2016) Stéphanie Humblet-Baron et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
- (2016) Lisa Pleyer et al. Journal of Hematology & Oncology
- Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
- (2016) Nicolaus Kröger et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
- (2015) A. de Masson et al. BLOOD
- 5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft
- (2015) J Steinmann et al. BONE MARROW TRANSPLANTATION
- Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning
- (2015) M. Hannon et al. CLINICAL CANCER RESEARCH
- Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood—a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation
- (2015) Frédéric Baron et al. Journal of Hematology & Oncology
- Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society
- (2015) Frédéric Baron et al. Journal of Hematology & Oncology
- Current issues in chronic graft-versus-host disease
- (2014) G. Socie et al. BLOOD
- Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
- (2014) F Baron et al. BONE MARROW TRANSPLANTATION
- Increased Th17/Treg ratio in chronic liver GVHD
- (2014) F Malard et al. BONE MARROW TRANSPLANTATION
- Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)
- (2014) Yong-rong Lai et al. Journal of Hematology & Oncology
- Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
- (2014) G. Lal et al. JOURNAL OF IMMUNOLOGY
- Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation
- (2014) Marilène Binsfeld et al. PLoS One
- Development and Maintenance of Regulatory T cells
- (2013) Naganari Ohkura et al. IMMUNITY
- Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients
- (2013) Lieke H van der Helm et al. Journal of Hematology & Oncology
- Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4+ and CD8+ T Cells
- (2013) T. Wu et al. JOURNAL OF IMMUNOLOGY
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
- (2012) O. C. Goodyear et al. BLOOD
- Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation
- (2012) R. J. Robb et al. BLOOD
- Comparative Outcomes of Donor Graft CD34+Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
- (2012) Marcelo C. Pasquini et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity
- (2012) A. J. Beres et al. JOURNAL OF IMMUNOLOGY
- Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation
- (2012) F Baron et al. LEUKEMIA
- Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
- (2011) G. Socie et al. BLOOD
- Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation
- (2011) Y. Kawano et al. BLOOD
- Mouse models of graft-versus-host disease: advances and limitations
- (2011) M. A. Schroeder et al. Disease Models & Mechanisms
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
- (2011) John R. Wingard et al. JOURNAL OF CLINICAL ONCOLOGY
- In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
- (2010) J. Choi et al. BLOOD
- Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age
- (2010) E. Castermans et al. HAEMATOLOGICA
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation
- (2010) Ken-ichi Matsuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation
- (2010) S Thepot et al. LEUKEMIA
- Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting
- (2009) L. I. Sanchez-Abarca et al. BLOOD
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues
- (2008) Yu-Waye Chu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy
- (2008) José A. Pérez-Simón et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease
- (2008) D. Zhao et al. BLOOD
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now